Synthesis and Pharmacological Evaluation of Dual Acting Ligands Targeting the Adenosine A2A and Dopamine D2 Receptors for the Potential Treatment of Parkinson’s Disease
Author:
Affiliation:
1. Neural Pathways DPU, Neurosciences TAU, GSK R&D, 11 Biopolis Way, Helios Bldg #03-01/02, Singapore 138667, Singapore
Funder
GlaxoSmithKline
Australian Research Council
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm501254d
Reference51 articles.
1. Alzheimer's Disease and Parkinson's Disease
2. Parkinson's disease
3. Emerging therapies for Parkinsonʼs disease
4. Dopamine miracle: From brain homogenate to dopamine replacement
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An operationally simple, one‐pot, convenient synthesis, and in vitro anti‐inflammatory activity of some new spirotriazolotriazine derivatives;Journal of Heterocyclic Chemistry;2023-11-08
2. Study of G protein-coupled receptors dimerization: From bivalent ligands to drug-like small molecules;Bioorganic Chemistry;2023-11
3. Striatal astrocytic A2A-D2 receptor-receptor interactions and their role in neuropsychiatric disorders;Neuropharmacology;2023-10
4. Modulating brain integrative actions as a new perspective on pharmacological approaches to neuropsychiatric diseases;Frontiers in Endocrinology;2023-01-09
5. Developing Photoaffinity Probes for Dopamine Receptor D2 to Determine Targets of Parkinson’s Disease Drugs;ACS Chemical Neuroscience;2022-10-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3